"In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening diseases," writes Shirley Tilghman, president emeritus of Princeton University and a professor of Molecular Biology and Public Affairs. "Yet, despite decades of bipartisan support for science as an engine for economic growth, the White House has released a budget proposal for 2018 that seeks to walk away from this investment, drastically reducing federal funding for science and threatening our ability to continue making Americans healthier and more prosperous."
Read the full article, co-authored by Roy Vagelos, retired chairman, and CEO of Merck & Co., Inc., in the Opinion Section of nj.com.